Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,477 | -2,536 | -71,327 | -28,177 | -18,890 |
| Depreciation Amortization | 461 | 232 | 286 | 168 | 41 |
| Income taxes - deferred | N/A | N/A | 1,052 | -63 | -1,221 |
| Accounts receivable | 1,531 | 2,217 | N/A | -1,543 | 0 |
| Accounts payable and accrued liabilities | -624 | -1,086 | -69 | -86 | 116 |
| Other Working Capital | 3,643 | 2,259 | 3,179 | -11 | 1,409 |
| Other Operating Activity | -3,554 | -9,134 | 37,950 | 9,275 | 6,091 |
| Operating Cash Flow | $-21,020 | $-8,048 | $-28,929 | $-20,437 | $-12,454 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 3,911 | 1,392 | 578 |
| PPE Investments | -29 | -22 | -320 | -554 | -450 |
| Net Acquisitions | -2,315 | -2,010 | N/A | -10,075 | -10,083 |
| Other Investing Activity | 0 | 0 | -15,631 | 1 | -1 |
| Investing Cash Flow | $-2,344 | $-2,032 | $-12,040 | $-9,236 | $-9,956 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,865 | 9,865 | 9,865 |
| Debt Repayment | -7 | -3 | N/A | -21 | -17 |
| Common Stock Issued | 14,746 | 14,723 | 46,084 | 38,418 | 674 |
| Financing Cash Flow | $14,739 | $14,720 | $55,949 | $48,262 | $10,522 |
| Beginning Cash Position | 47,787 | 47,787 | 32,807 | 32,807 | 32,807 |
| End Cash Position | 39,162 | 52,427 | 47,787 | 51,396 | 20,919 |
| Net Cash Flow | $-8,625 | $4,640 | $14,980 | $18,589 | $-11,888 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,020 | -8,048 | -28,929 | -20,437 | -12,454 |
| Capital Expenditure | -29 | -22 | -320 | -554 | -450 |
| Free Cash Flow | -21,049 | -8,070 | -29,249 | -20,991 | -12,904 |